Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10584114 Inhibitors of RET

Patent 10584114 was granted and assigned to Blueprint Medicines on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Blueprint Medicines

Current Assignee

Blueprint Medicines

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

March 10, 2020

Patent Application Number

16041719

Date Filed

July 20, 2018

Patent Citations

US Patent 10183928 Inhibitors of RET

US Patent 10196436 Inhibitors of the fibroblast growth factor receptor

US Patent 10202365 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

US Patent 10227329 Compounds useful for treating disorders related to RET

US Patent 10221154 Inhibitors of the fibroblast growth factor receptor

US Patent 10000490 Inhibitors of the fibroblast growth factor receptor

US Patent 10000496 Compositions useful for treating disorders related to kit and PDGFR

US Patent 10017512 Compounds and compositions useful for treating disorders related to NTRK

...

Patent Citations Received

US Patent 12060354 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11964980 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11993613 Thiazolo[5,4-b]pyridine MALT-1 inhibitors

0

US Patent 11999744 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

US Patent 11273160 RET inhibitor for use in treating cancer having a RET alteration

US Patent 11279688 Inhibitors of RET

US Patent 11872192 RET inhibitor for use in treating cancer having a RET alteration

0

...

Patent Primary Examiner

Alexander R Pagano

Patent abstract

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10584114 Inhibitors of RET

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool